Price Target Reduction#
Cantor Fitzgerald has lowered its price target for Alexandria Real Estate Equities (NYSE: ARE) from $60 to $43 while keeping a Neutral rating. The stock is currently trading at $40.86, reflecting a 13% decline over the past week and a significant 41% drop over the last year.
Earnings Performance and Challenges#
In its first quarter of 2026, Alexandria reported funds from operations (FFO) of $1.73 per share, meeting expectations. However, the company is facing several challenges, including an oversupply of life science properties, commitments for development funding, and regulatory uncertainties from agencies like HHS, FDA, and NIH. Additionally, there are known lease expirations that could impact future earnings. Despite these challenges, Alexandria maintains a 7.1% dividend yield and has consistently paid dividends for 30 years.
Adjusted Earnings Estimates#
Cantor Fitzgerald has revised its earnings estimates for 2027 following an earnings reset communicated by Alexandria during its December 2025 investor day. The firm believes that Alexandria will need another year before establishing a stable earnings floor.
Industry Outlook#
On a more positive note, the biotech sector has shown signs of recovery, with recent merger and acquisition activity and an 8% increase in the XBI index year-to-date. Cantor Fitzgerald noted that the strategic steps Alexandria is taking could position the company well for an eventual recovery in the industry. The new price target of $43 is based on a 9x multiple of 2026 adjusted funds from operations, reflecting the current market valuation of the company.
In a recent earnings report, Alexandria posted an impressive earnings per share (EPS) of $2.10, significantly exceeding analyst expectations of $0.15, marking a 1300% increase. However, the company's revenue fell short of projections, totaling $671.02 million against an anticipated $684.24 million, indicating mixed financial performance in the first quarter.